The murine inhibitory receptor mSiglec-E is expressed broadly on cells of the innate immune system whereas mSiglec-F is restricted to eosinophils

European Journal of Immunology

Volumn 34, Issue 4, 2004, Pages 1175-1184

  Zhang, Jiquan Q ^a   Biedermann, Björn ^b   Nitschke, Lars ^b   Crocker, Paul R ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

^b UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Adhesion molecules; Cell surface molecules; Eosinophils; Neutrophils; Rodent

Indexed keywords

BINDING PROTEIN; GENOMIC DNA; LECTIN; SIALIC ACID; SIGLEC E; SIGLEC F; UNCLASSIFIED DRUG; B LYMPHOCYTE ANTIGEN; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN; SIGLEC E ANTIGEN, MOUSE; SIGLEC F PROTEIN, MOUSE; SIGLEC-E ANTIGEN, MOUSE; SIGLEC-F PROTEIN, MOUSE;

ANIMAL CELL; ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; CELL MATURATION; CHO CELL; CONTROLLED STUDY; DENDRITIC CELL; EFFECTOR CELL; EOSINOPHIL; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; IMMUNE SYSTEM; IMMUNOBLOTTING; IMMUNOPRECIPITATION; LYMPHOCYTE SUBPOPULATION; MACROPHAGE; NATURAL KILLER CELL; NONHUMAN; NUCLEOTIDE SEQUENCE; PERITONEAL CAVITY; PRIORITY JOURNAL; WESTERN BLOTTING; ANIMAL; BONE MARROW CELL; COMPARATIVE STUDY; CYTOLOGY; FLOW CYTOMETRY; HUMAN; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOLECULAR GENETICS; MOUSE; NEUTROPHIL; SEQUENCE HOMOLOGY; SPLEEN; STEM CELL;

ANIMALS; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, B-LYMPHOCYTE; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; B-LYMPHOCYTES; BASE SEQUENCE; BONE MARROW CELLS; DENDRITIC CELLS; EOSINOPHILS; FLOW CYTOMETRY; HUMANS; IMMUNITY, NATURAL; KILLER CELLS, NATURAL; MACROPHAGES; MICE; MOLECULAR SEQUENCE DATA; NEUTROPHILS; PERITONEAL CAVITY; SEQUENCE HOMOLOGY, NUCLEIC ACID; SPLEEN; STEM CELLS;

EID: 3843145244     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200324723     Document Type: Article

References (31)

1. Crocker, P. R., Siglecs: sialic-acid-binding immunoglobulin-like lectins in cell-cell interactions and signaling. Curr. Opin. Struct. Biol. 2002. 12: 609-615.
2. Crocker, P. R. and Varki, A., Siglecs, sialic acids and innate immunity. Trends Immunol. 2001. 22: 337-342.
3. Falco, M., Biassoni, R., Bottino, C., Vitale, M., Sivori, S., Augugliaro, R., Moretta, L. and Moretta, A., Identification and molecular cloning of p75/AIRM1, a novel member of the sialoadhesin family that functions as an inhibitory receptor in human natural killer cells. J. Exp. Med. 1999. 190: 793-801.
4. Ulyanova, T., Blasioli, J., Woodford-Thomas, T. A. and Thomas, M. L., The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur. J. Immunol. 1999. 29: 3440-3449.
5. Paul, S. P., Taylor, L. S., Stansbury, E. K. and McVicar, D. W., Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood 2000. 96: 483-490.
6. Ulyanova, T., Shah, D. D. and Thomas, M. L., Molecular cloning of MIS, a myeloid inhibitory siglec that binds tyrosine phosphatases SHP-1 and SHP-2. J. Biol. Chem. 2001. 276: 14451-14458.
7. Lanoue, A., Batista, F. D., Stewart, M. and Neuberger, M. S., Interaction of CD22 with alpha2,6-linked sialoglycoconjugates: innate recognition of self to dampen B cell autoreactivity? Eur. J. Immunol. 2002. 32: 348-355.
8. Kelm, S., Gerlach, J., Brossmer, R., Danzer, C. P. and Nitschke, L., The ligand-binding domain of CD22 is needed for inhibition of the B cell receptor signal, as demonstrated by a novel human CD22-specific inhibitor compound. J. Exp. Med. 2002. 195: 1207-1213.
9. Jin, L., McLean, P. A., Neel, B. G. and Wortis, H. H., Sialic acid binding domains of CD22 are required for negative regulation of B cell receptor signaling. J. Exp. Med. 2002. 195: 1199-1205.
10. Vitale, C., Romagnani, C., Falco, M., Ponte, M., Vitale, M., Moretta, A., Bacigalupo, A., Moretta, L. and Mingari, M. C., Engagement of p75/AIRM1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. Proc. Natl. Acad. Sci. USA 1999. 96: 15091-15096.
11. + myeloid precursors. Eur. J. Immunol. 2000. 30: 827-833.
12. Nutku, E., Aizawa, H., Hudson, S. A. and Bochner, B. S., Ligation of Siglec-8: a selective mechanism for induction of human eosinophil apoptosis. Blood 2003. 101: 5014-5020.
13. Angata, T., Hingorani, R., Varki, N. M. and Varki, A., Cloning and characterization of a novel mouse Siglec, mSiglec-F: differential evolution of the mouse and human (CD33) Siglec-3-related gene clusters. J. Biol. Chem. 2001. 276: 45128-45136.
14. Yu, Z., Maoui, M., Wu, L., Banville, D. and Shen, S.-H., mSiglec-E, a novel mouse CD33-related siglec (sialic acid binding immunoglobulin-like lectin) that recruits Src homology 2 (SH2)-domain containing protein tyrosine phosphatases SHP-1 and SHP-2. Biochem. J. 2001. 353: 483-492.
15. Angata, T. and Varki, A., Siglec-7: a sialic acid-binding lectin of the immunoglobulin superfamily. Glycobiology 2000. 10: 431-438.
16. Nicoll, G., Ni, J., Liu, D., Klenerman, P., Munday, J., Dubock, S., Mattei, M. G. and Crocker, P. R., Identification and characterization of a novel siglec, siglec-7, expressed by human natural killer cells and monocytes. J. Biol. Chem. 1999. 274: 34089-34095.
17. Cornish, A. L., Freeman, S., Forbes, G., Ni, J., Zhang, M., Cepeda, M., Gentz, R., Augustus, M., Carter, K. C. and Crocker, P. R., Characterization of siglec-5, a novel glycoprotein expressed on myeloid cells related to CD33. Blood 1998. 92: 2123-2132.
18. Floyd, H., Ni, J., Cornish, A. L., Zeng, Z., Liu, D., Carter, K. C., Steel, J. and Crocker, P. R., Siglec-8. A novel eosinophil-specific member of the immunoglobulin superfamily. J. Biol. Chem. 2000. 275: 861-866.
19. Gurish, M. F., Humbles, A., Tao, H., Finkelstein, S., Boyce, J. A., Gerard, C., Friend, D. S. and Austen, K. F., CCR3 is required for tissue eosinophilia and larval cytotoxicity after infection with Trichinella spiralis. J. Immunol. 2002. 168: 5730-5736.
20. Sabroe, I., Hartnell, A., Jopling, L. A., Bel, S., Ponath, P. D., Pease, J. E., Collins, P. D. and Williams, T. J., Differential regulation of eosinophil chemokine signaling via CCR3 and non-CCR3 pathways. J. Immunol. 1999. 162: 2946-2955.
21. Kim, S., Iizuka, K., Kang, H. S., Dokun, A., French, A. R., Greco, S. and Yokoyama, W. M., In vivo developmental stages in murine natural killer cell maturation. Nat. Immunol. 2002. 3: 523-528.
22. Matsuda, J. L., Naidenko, O. V., Gapin, L., Nakayama, T., Taniguchi, M., Wang, C. R., Koezuka, Y. and Kronenberg, M., Tracking the response of natural killer T cells to a glycolipid antigen using CD1d tetramers. J. Exp. Med. 2000. 192: 741-754.
23. Hardy, R. R. and Hayakawa, K., B cell development pathways. Annu. Rev. Immunol. 2001. 19: 595-621.
24. Crocker, P. R. and Zhang, J., New I-type lectins of the CD33-related siglec subgroup identified through genomics. Biochem. Soc. Symp. 2002: 83-94.
25. Martin, F. and Kearney, J. F., Marginal-zone B cells. Nat. Rev. Immunol. 2002. 2: 323-335.
26. Angata, T. and Varki, A., Cloning, characterization, and phylogenetic analysis of siglec-9, a new member of the CD33-related group of siglecs. Evidence for co-evolution with sialic acid synthesis pathways. J. Biol. Chem. 2000. 275: 22127-22135.
27. Zhang, J. Q., Nicoll, G., Jones, C. and Crocker, P. R., Siglec-9, a novel sialic acid binding member of the immunoglobulin superfamily expressed broadly on human blood leukocytes. J. Biol. Chem. 2000. 275: 22121-22126.
28. Yamaji, T., Teranishi, T., Alphey, M. S., Crocker, P. R. and Hashimoto, Y., A small region of the natural killer cell receptor, Siglec-7, is responsible for its preferred binding to alpha 2,8-disialyl and branched alpha 2,6-sialyl residues. A comparison with Siglec-9. J. Biol. Chem. 2002. 277: 6324-6332.
29. Nicoll, G., Avril, T., Lock, K., Furukawa, K., Bovin, N. and Crocker, P. R., Ganglioside GD3 expression on target cells can modulate NK cell cytotoxicity via siglec-7-dependent and -independent mechanisms. Eur. J. Immunol. 2003. 33: 1642-1648.
30. Kelm, S., Pelz, A., Schauer, R., Filbin, M. T., Tang, S., de Bellard, M. E., Schnaar, R. L., Mahoney, J. A., Hartnell, A., Bradfield, P. and Crocker, P. R., Sialoadhesin, myelin-associated glycoprotein and CD22 define a new family of sialic acid-dependent adhesion molecules of the immunoglobulin superfamily. Curr. Biol. 1994. 4: 965-972.
31. Vinson, M., van der Merwe, P. A., Kelm, S., May, A., Jones, E. Y. and Crocker, P. R., Characterization of the sialic acid-binding site in sialoadhesin by site-directed mutagenesis. J. Biol. Chem. 1996. 271: 9267-9272.